IMMUNOLOGICAL STUDY OF THE ASPLENIA SYNDROME

被引:16
作者
WANG, JK
HSIEH, KH
机构
[1] Department of Pediatrics, National Taiwan University Hospital, Taipei
关键词
ASPLENIA SYNDROME; IMMUNE FUNCTION; RETICULOENDOTHELIAL FUNCTION; FC RECEPTOR FUNCTION; T-CELL FUNCTION;
D O I
10.1097/00006454-199111000-00005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Asplenia syndrome is usually associated with complex congenital cardiovascular defects. These patients often succumb to overwhelming infections. A complete immunological evaluation was therefore conducted on 13 consecutive patients with asplenia syndrome and 12 age-matched patients with congenital heart disease but without evident splenic problems. IgG, IgA, IgM and C3 and C4 values were normal for age in all subjects studied. T cell subsets, including the percentage of CD3, and CD4 cells and the CD4/CD8 ratio were significantly different in patients and controls (P < 0.01, respectively). Lymphoproliferative responses to mitogens (ConA, concanavalin A, phytohemagglutinin and pokeweed mitogen) were also decreased in patients. Fc-mediated clearance of sensitized autologous erythrocytes was significantly impaired in patients (n = 13) when compared with age-matched controls (n = 5) (clearance t1/2 59.0 +/- 9.6 minutes vs. 12.5 +/- 1.6 minutes, P < 0.001). Thus profoundly impaired reticuloendothelial clearance and decreased T cell function might account for the life-threatening infections frequently seen in patients with congenital asplenia syndrome.
引用
收藏
页码:819 / 822
页数:4
相关论文
共 27 条
[1]   STUDIES ON INVIVO EFFECTS OF ANTIBODY - INTERACTION OF IGM ANTIBODY AND COMPLEMENT IN IMMUNE CLEARANCE AND DESTRUCTION OF ERYTHROCYTES IN MAN [J].
ATKINSON, JP ;
FRANK, MM .
JOURNAL OF CLINICAL INVESTIGATION, 1974, 54 (02) :339-348
[2]  
BIGGAR WD, 1981, PEDIATRICS, V67, P548
[3]   SYNDROME OF ASPLENIA, PNEUMOCOCCAL SEPSIS, AND DISSEMINATED INTRAVASCULAR COAGULATION [J].
BISNO, AL ;
FREEMAN, JC .
ANNALS OF INTERNAL MEDICINE, 1970, 72 (03) :389-+
[4]  
BRADLEY LM, 1980, SELECTED METHODS IMM, P158
[5]  
CHIU IS, 1988, BRIT HEART J, V60, P72
[6]  
DEANFIELD JE, 1980, BRIT HEART J, V44, P577
[7]  
HAMMARSTROM L, 1986, CLIN EXP IMMUNOL, V66, P457
[8]  
HOSEA SW, 1981, LANCET, V1, P804
[9]  
HSIEH K-H, 1978, Acta Paediatrica Sinica, V19, P301
[10]  
HUHTA JC, 1982, BRIT HEART J, V48, P97